Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 3,101,240 | 2,819,160 | 2,818,004 | 2,431,198 | 3,153,040 |
| Cost of Goods | 837,220 | 642,060 | 738,648 | 606,179 | 883,520 |
| Gross Profit | 2,264,020 | 2,177,100 | 2,079,364 | 1,825,019 | 2,269,520 |
| Operating Expenses | 1,582,820 | 1,597,420 | 1,572,333 | 1,649,132 | 1,756,120 |
| Operating Income | 680,600 | 579,740 | 507,670 | 174,237 | 514,800 |
| Interest Expense | 3,280 | 2,460 | 2,271 | -288 | 880 |
| Other Income | 3,280 | 60,680 | 49,446 | 37,507 | 4,400 |
| Pre-tax Income | 680,600 | 637,960 | 554,845 | 212,031 | 518,320 |
| Income Tax | 175,480 | 159,080 | 188,944 | 47,899 | 124,960 |
| Net Income Continuous | 505,120 | 478,880 | 365,900 | 164,132 | 393,360 |
| Net Income | $505,120 | $478,060 | $365,900 | $163,252 | $394,240 |
| EPS Basic Total Ops | 0.23 | 0.22 | 0.17 | 0.08 | 0.18 |
| EPS Basic Continuous Ops | 0.23 | 0.22 | 0.17 | 0.08 | 0.18 |
| EPS Diluted Total Ops | 0.23 | 0.22 | 0.17 | 0.07 | 0.18 |
| EPS Diluted Continuous Ops | 0.23 | 0.22 | 0.17 | 0.08 | 0.18 |
| EBITDA(a) | $828,536 | $724,945 | $650,137 | $348,846 | $635,264 |